SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ARRIS - Another partner

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Andrew H who wrote (298)12/8/1997 10:20:00 PM
From: Marshall Teitelbaum  Read Replies (1) of 353
 
Andrew,

One possibility, at least partially, influencing the rally today may have been the new issue(dec.) of Worth. Just came in the mail for me today. On page 39, in the article entitled "What They're Buying, 1998,", it was listed as one of the two picks for the year by, you got it, Micheal Murphy....rated as a buy up to 14$, and gave expectation of 28$ by the end of the year(98).. The article also listed a few of Al Frank, W. Nasgovitz, J. McCamant, etc. Others mentioned by MM were IDTI for this year, with ARRS, and mentioned his two picks from last year, XOMA(continue to hold) and CHIR(raised buy limit up to 25 due to his opinion of excellent prospects).

Well, that covers it for me. FWIW, I like this combo.(sqna and arrs) of companies for the long haul...they covered one of the things necessary for the long-term growth and survival, as long as they get a few products out over the next several years.

Regards,

Marshall
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext